These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11345202)

  • 1. Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia.
    Aihara K; Azuma H; Ikeda Y; Akaike M; Abe M; Sugihara T; Matsumoto T
    Int J Hematol; 2001 Apr; 73(3):351-5. PubMed ID: 11345202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe alcoholic cirrhosis associated with spur cell anemia and DIC].
    Fukuda T; Baba Y; Tanaka M; Ishibashi H; Hirata Y; Okamura T; Kudo J; Niho Y; Yamanaka M
    Fukuoka Igaku Zasshi; 1991 Jun; 82(6):398-402. PubMed ID: 1885127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-loading of membranes of normal erythrocytes inhibits phospholipid repair and arachidonoyl-CoA:1-palmitoyl-sn-glycero-3-phosphocholine acyl transferase. A model of spur cell anemia.
    Allen DW; Manning N
    Blood; 1996 Apr; 87(8):3489-93. PubMed ID: 8605368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte lipid alterations in pediatric cholestatic liver disease: spur cell anemia of infancy.
    Cynamon HA; Isenberg JN; Gustavson LP; Gourley WK
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):542-9. PubMed ID: 4032166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cholesterol and decreased fluidity of red cell membranes (spur cell anemia) in progressive intrahepatic cholestasis.
    Balistreri WF; Leslie MH; Cooper RA
    Pediatrics; 1981 Apr; 67(4):461-6. PubMed ID: 7254967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver alcoholic cirrhosis and spur-cell (acanthocytic) anaemia. A study of erythrocyte ghost composition and fluidity.
    Arienti G; Carlini E; Scionti L; Puxeddu E; Brunetti P
    Scand J Gastroenterol; 1995 Dec; 30(12):1204-9. PubMed ID: 9053975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
    N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunarizine treatment for spur cell anaemia.
    Fossaluzza V; Rossi P
    Br J Haematol; 1983 Dec; 55(4):715-7. PubMed ID: 6671091
    [No Abstract]   [Full Text] [Related]  

  • 9. Spur cell anemia.
    Doll DC; Doll NJ
    South Med J; 1982 Oct; 75(10):1205-10. PubMed ID: 7123289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
    Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study on the membrane of spur cells.
    Takemoto Y; Kohama A; Shibata S
    Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):858-67. PubMed ID: 6507014
    [No Abstract]   [Full Text] [Related]  

  • 12. An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease.
    Cooper RA; Diloy Puray M; Lando P; Greenverg MS
    J Clin Invest; 1972 Dec; 51(12):3182-92. PubMed ID: 4640953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal phospholipid metabolism in spur cell anemia: decreased fatty acid incorporation into phosphatidylethanolamine and increased incorporation into acylcarnitine in spur cell anemia erythrocytes.
    Allen DW; Manning N
    Blood; 1994 Aug; 84(4):1283-7. PubMed ID: 8049442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
    Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spur-cell anemia in alcoholic liver cirrhosis].
    Dijkhuis AM; Baggen MG; Montfoort A; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):716-8. PubMed ID: 2038398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial.
    Ballantyne CM; Miller E; Chitra R
    Clin Ther; 2004 Nov; 26(11):1855-64. PubMed ID: 15639697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin.
    Martínez M; Vayá A; Martí R; Gil L; Lluch I; Carmena R; Aznar J
    Thromb Res; 1996 Sep; 83(5):375-88. PubMed ID: 8873346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
    Series JJ; Caslake MJ; Kilday C; Cruickshank A; Demant T; Lorimer AR; Packard CJ; Shepherd J
    Metabolism; 1989 Feb; 38(2):153-8. PubMed ID: 2643751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.